3Graziano F, Catalano V, Baldelli AM,et al. A phase Ⅱ study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer[ J ]. Ann Oncol, 2000, 11 (10) : 1263 - 1266.
4Macdonald JS. Clinical overview: adjuvant therapy of gastrointestional cancer[ J ]. Cancer chemother pharmacol, 2004, 54 ( suppl1):S4-11.
5Yoshida K, Tanabe K, Ueno H, et al. Future prospects of personalized chemotherapy in gastric cancer patients: results of a prospective randomized pilot study. [ J]. Gastric Cancer, 2003,6(Suppl 1) :82 -89.
6Sohn JH, Jeung HC, Shin H J, et al. Infusional fluorouracil, etoposide, and cisplatin (FEP) in advanced and relapsed gastric cancer[J]. Am J Clin Oncol, 2003, 26 (2) :203 - 209.
7Li Y, Poliks B,Cegelski L, et al. Conformation of microtubule-bound paclitaxel determined by fluorescence spectroscopy and REDOR NMR [J]. biochemistry., 2000, 39 (2) : 281 - 291.
8Montagut C, Marmol M, Rey V, et al. Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus [J]. Gynecol Oncol, 2003, 90(2) : 458 -461.
9Belani CP, Barstis J,Perry MC, et al. Multicenter, randomized trial for stang Ⅲ B or Ⅳ non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel of observation [J]. J Clin Oncol, 2003, 21 ( 15 ) : 2933- 2939.
10Constenla M, Garcia-Arroyo R, Lorenzo I, et al. Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer, results of a phase Ⅱ study [J]. Gastric Cancer, 2002:5(3) :142 -147.
